This website is being reviewed for updates. Some information is offline. We apologize for any inconvenience.
Skip to main content
Rural Health Information Hub
Rural Health Information Hub

Rural Health
News by Topic: Pharmacy and prescription drugs

May 16, 2025 - Notice from the Centers for Medicare & Medicaid Services (CMS) making technical and typographic corrections to the December 9, 2024, final rule and the December 30, 2024, correcting amendment. The corrections and correcting amendment are effective May 16, 2025, and applicable beginning January 1, 2025.
Source: Federal Register
May 13, 2025 - The Centers for Medicare & Medicaid Services (CMS) is seeking comments on the following information collections: 1) Medicare Geographic Classification Review Board Procedures and Criteria and 2) Part C and Part D Medicare Prescription Payment Plan Model Documents. Comments are due by July 14, 2025.
Source: Federal Register
May 12, 2025 - The Centers for Medicare & Medicaid Services is seeking comments on the following information collections: 1) Laboratory Personnel Report (CLIA) and Supporting Regulations; 2) End Stage Renal Disease (ESRD) Conditions for Coverage and Supporting Regulations; 3) Hospice Information for Medicare Part D Plans; 4) Part D Coordination of Benefits Data; and 5) Requirements Related to Surprise Billing: Qualifying Payment Amount, Notice and Consent, Disclosure on Patient Protections Against Balance Billing, and State Law Opt-in. Comments are due by June 11, 2025.
Source: Federal Register
Apr 15, 2025 - Notice of final rule from the Centers for Medicare & Medicaid Services (CMS) revising the Medicare Advantage (Part C), Medicare Prescription Drug Benefit (Part D), Medicare cost plan, and Programs of All-Inclusive Care for the Elderly (PACE) regulations to implement changes related to prescription drug coverage, the Medicare Prescription Payment Plan, dual eligible special needs plans (D-SNPs), Part C and Part D Star Ratings, and other programmatic areas, including the Medicare Drug Price Negotiation Program. This final rule also codifies existing sub-regulatory guidance in the Part C and Part D programs. These regulations are effective June 3, 2025.
Source: Federal Register
Apr 1, 2025 - Notice from the Centers for Medicare & Medicaid Services (CMS) seeking comments on an information collection Medicare Transaction Facilitator (MTF) for 2026 and 2027 under Sections 11001 and 11002 of the Inflation Reduction Act (IRA). The MTF will collect information from manufacturers of drugs covered under Medicare Part D selected will be used for negotiation under the Inflation Reduction Act for the initial price applicability years 2026 and 2027 and the dispensing entities that dispense the selected drugs to MFP-eligible individuals. Comments are due by May 1, 2025.
Source: Federal Register
Mar 24, 2025 - Notice of final rule from the Drug Enforcement Administration and U.S. Department of Health and Human Services (HHS) further delaying the January 17, 2025, final rules titled "Expansion of Buprenorphine Treatment via Telemedicine Encounter" and "Continuity of Care via Telemedicine for Veterans Affairs Patients." These final rules will now be effective December 31, 2025.
Source: Federal Register